NCT05740215 2023-02-22
Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors
Shandong New Time Pharmaceutical Co., LTD
Phase 1/2 Unknown
Shandong New Time Pharmaceutical Co., LTD
Mabwell (Shanghai) Bioscience Co., Ltd.
Mabwell (Shanghai) Bioscience Co., Ltd.
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences